Not finding it? Sign in to also search OpenAlex live.
-
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program
Leanne P. M. van Leeuwen, Marloes Grobben, Corine H. GeurtsvanKessel, Pauline M. Ellerbroek, Godelieve J. de Bree, Judith Potjewijd, +6 more
8citations -
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial
Ngoc H. Tan, Daryl Geers, Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, Douwe F. Postma, +18 more
37citations -
Highly Sensitive Flow Cytometry Allows Monitoring of Changes in Circulating Immune Cells in Blood After Tdap Booster Vaccination2021 Frontiers in Immunology article Immunology and Microbiology Bacterial Infections and Vaccines Open access
Annieck M. Diks, Indu Khatri, Liesbeth E.M. Oosten, Bas de Mooij, Rick J. Groenland, Cristina Teodósio, +6 more
24citations -
Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination2022 The Journal of Infectious Diseases article Medicine SARS-CoV-2 and COVID-19 Research Open access
Marlou J. Jongkees, Daryl Geers, Kathryn S. Hensley, Wesley Huisman, Corine H. GeurtsvanKessel, Susanne Bogers, +24 more
19citations -
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS2022 Nephrology Dialysis Transplantation article Medicine SARS-CoV-2 and COVID-19 Research Open access
Kate Stevens, Eleni A. Frangou, Jae Il Shin, Hans‐Joachim Anders, Annette N. Bruchfeld, Ulf Schönermarck, +13 more
30citations -
T-cell responses to primary SARS-CoV-2 vaccination in Down syndrome – From childhood to adulthood2026 Human Vaccines & Immunotherapeutics article Medicine SARS-CoV-2 and COVID-19 Research Open access
Lobke C.M. Hensen, Bianca M. M. Streng, Femke van Wijk, Stefan Nierkens, Joanne Wildenbeest, Louis Bont, +16 more
0citations -
A model for establishment, maintenance and reactivation of the immune response after vaccination against Ebola virus2020 Journal of Theoretical Biology article Medicine Viral Infections and Outbreaks Research Open access
Irène Balelli, Chloé Pasin, Mélanie Prague, Fabien Crauste, Thierry Van Effelterre, Viki Bockstal, +2 more
24citations -
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa2021 PLoS Medicine article Medicine Viral Infections and Outbreaks Research Open access cited by 1 patent
Houreratou Barry, Gaudensia Nzembi Mutua, Hannah N. Kibuuka, Zacchaeus Anywaine, Sodiomon Bienvenu Sirima, Nicolas Méda, +17 more
69citations -
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial2022 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access
Daniela Manno, Agnes Bangura, Frank Baiden, A Kamara, Philip Ayieko, J A Kallon, +24 more
27citations -
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection2022 Nature Communications article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 2 patents
Iris N. Pardieck, Tetje Cornelia van der Sluis, Esmé T.I. van der Gracht, Dominique M. B. Veerkamp, Felix M. Behr, Suzanne van Duikeren, +20 more
54citations